Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950149-03-000669
Filing Date
2003-03-25
Accepted
2003-03-25 16:08:08
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K f88257e10vk.htm 10-K 644636
3 EXHIBIT 10.20 f88257exv10w20.htm EX-10.20 176605
4 EXHIBIT 10.21 f88257exv10w21.htm EX-10.21 161628
5 EXHIBIT 10.23 f88257exv10w23.htm EX-10.23 33764
6 EXHIBIT 10.31 f88257exv10w31.htm EX-10.31 11234
7 EXHIBIT 10.32 f88257exv10w32.htm EX-10.32 11163
8 EXHIBIT 23.1 f88257exv23w1.htm EX-23.1 1479
9 EXHIBIT 99.1 f88257exv99w1.htm EX-99.1 3014
  Complete submission text file 0000950149-03-000669.txt   1045864
Mailing Address 3031 RESEARCH DRIVE RICHMOND CA 94806
Business Address 3031 RESEARCH DR BLDG A RICHMOND CA 94806 5102229700
ONYX PHARMACEUTICALS INC (Filer) CIK: 0001012140 (see all company filings)

EIN.: 943154463 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-28298 | Film No.: 03615892
SIC: 2836 Biological Products, (No Diagnostic Substances)